Metabolic control in type 2 diabetic patients treated with empagliflozin: A case series.

Wilfredo Navarrete Pilar Durruty Eileen Andrade Rodrigo Orellana María Georgina Ortiz María Angélica Budini

Published in: Medwave (2024)

Patients with type 2 diabetes mellitus with insulin requirements treated with empagliflozin at the Peñaflor Hospital achieved better glycemic control with few adverse effects.

Keyphrases

glycemic control
type diabetes
newly diagnosed
end stage renal disease
ejection fraction
blood glucose
weight loss
emergency department
patient reported outcomes
skeletal muscle